Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-06-27
2006-06-27
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S253090, C514S253110, C544S360000, C544S364000
Reexamination Certificate
active
07067518
ABSTRACT:
A compound having 5-HT1Areceptor activity, represented by the chemical formulawherein:Ar is 2-methoxyphenyl, 1H-indol-4-yl or 2,3-dihydro-1,4-benzodioxin-5-yl;R1is 2-, 3- or 4-pyridyl;R2is H or C1-6alkyl;R3is H or C1-6alkyl; andR4is H or methyl,or an optical isomer thereof,or a pharmaceutically acceptable salt of such a compound or optical isomer.The invention also includes compositions containing such a compound, as well as methods for using a compound of the invention.
REFERENCES:
patent: 3717634 (1973-02-01), Wu et al.
patent: 4873331 (1989-10-01), Childers, Jr. et al.
patent: 4882432 (1989-11-01), Abou-Gharbia et al.
patent: 4988814 (1991-01-01), Abou-Gharbia et al.
patent: 5340812 (1994-08-01), Cliffe
patent: 5486518 (1996-01-01), Yardley et al.
patent: 5519025 (1996-05-01), Yardley et al.
patent: 0 395313 (1990-10-01), None
patent: WO 99/65887 (1999-12-01), None
patent: WO 00/35874 (2000-06-01), None
patent: WO 00/51999 (2000-09-01), None
patent: WO 00/52002 (2000-09-01), None
Jones et al. Pharmacology, Biochemistry and Behavior, vol. 71, p. 555-568 (2002).
Rasmussen, et al., “Section 1. Central nervous system diseases; Chap. 1. Recent Progress in Serotonin (5-HT)1AReceptor Modulators,” inAnnual Reports in Medicinal Chemistry, 1995, Bristol, J.A. (Ed.), 30, 1-9.
Zgombick, J.M., et al., “Pharmacological characterizations of recombinant human 5-TH1Dαreceptor subtypes coupled to adenylate cyclase inhibition in clonal cell lines: apparent differences in drug intrinsic efficacies between human 5-HT1Dsubtypes,”Naunyn-Schmiederberg's Arch Pharmacol, 1996, 354, 226-236.
Greenblatt Lynne P.
Kelly Michael G.
Palmer Yvette L.
Bernhardt Emily
Woodcock & Washburn LLP
Wyeth
LandOfFree
Pyridinyl-methyl-ethyl cyclohexanecarboxamides as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridinyl-methyl-ethyl cyclohexanecarboxamides as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridinyl-methyl-ethyl cyclohexanecarboxamides as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3693895